Internal Mammary Lymphadenopathy Does Not Impact Oncologic Outcomes in Patients Treated with Neoadjuvant Chemotherapy: Results from the I-SPY2 Clinical Trial.
作者:
主题词
人类(Humans);女(雌)性(Female);肿瘤辅助疗法(Neoadjuvant Therapy);中年人(Middle Aged);乳腺肿瘤(Breast Neoplasms);肿瘤复发, 局部(Neoplasm Recurrence, Local);预后(Prognosis);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);存活率(Survival Rate);随访研究(Follow-Up Studies);成年人(Adult);老年人(Aged);磁共振成像(Magnetic Resonance Imaging);化学疗法, 辅助(Chemotherapy, Adjuvant)
DOI
10.1245/s10434-024-15708-9
PMID
38980586
发布时间
2024-10-04
- 浏览0

Annals of surgical oncology
7420-7428页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文